2025 SPEAKERS
Mohamed Abdillahi, Senior Director, Risk Management, AstraZeneca
Ana Sofia Afonso, Director, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Gaetano Aiello, Senior Manager, PV System Excellence, Jazz Pharmaceuticals
Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)
Ibrahim Altamawy, Medical Affairs & Compliance Regional Head (MENA), SAJA Pharmaceuticals
Stefanie Amend-Mall, Director, Patient Safety HUB Europe, Sandoz
Anand Ananthakrishnan, Senior Director, Drug Safety and Pharmacovigilance, Blueprint Medicines
Sheela Ankolekar, Associate Director, Senior Pharmacovigilance Physician, Norgine Ltd
Wasim Anwar, Vice President, Head of QPPV Office, Novo Nordisk A/S
Julia Appelskog, Head of QPPV Office and PV Intelligence, CSL
Felix Arellano, Senior Vice President, Global Head of Safety and Risk Management, Roche
Simon Ashworth, Global Head of Safety, Menarini
Ercem Atillasoy, Chief Regulatory and Safety Officer, Jazz Pharmaceuticals
Mina G Awad, Pharmacovigilance Senior Manager and QPPV, Middle East, Kyowa Kirin International
Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals
Ikram Baig, CEO, Quartica
Dr Jamal Baig, Director, Pharmacovigilance, Multi Country Safety Head, Sanofi
Karen Baker, Global Safety Risk Management Lead, Sobi
Catherine Baldridge, Senior Director, Head of Safety, Fusion Pharma
Marianne Banoub, Regional Head of PV and QA, NewBridge Pharmaceutical
Erika Barbarosie, Associate Director, Compliance, Pharmaceuticals
Alexandru Barbarosie, EU/UK QPPV, Global Safety Lead, Amryt Pharma
Agnès Barrere, Local QPPV (RPV), France, Otsuka Pharmaceutical
Judy Barretto, Senior Director, Virology TA, Patient Safety, Gilead
Eniko Barta Kondas, Head, Global PV Operations, Gedeon Richter PLC
Lisa Benaise, Head of Global Pharmacovigilance, Miltenyi Biotec
Begum Benli Peker, Director, Head of Patient Safety Netherlands & EU Hub Lead, Bristol Myers Squibb
Blanca Berrocal Gonzalez, Head of Pharmacovigilance Compliance, Veterinary Medicines Directorate
Fabrice Besle, Head of Technology and Digital, Global Patient Safety, Ipsen
Kapil Bhutada, Senior Director, Safety Operations and Compliance, Medical Safety & Pharmacovigilance, AskBio
Mariette Boerstoel, Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb
Laura Paola Boga, Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé farmaceutici spa
Chris Bone, Director, Safety and Benefit Risk, Biogen
Ronald Boumans, Independent Medical Devices Expert, EU Medical Devices Expert
Barbara Bovy, Director, Head of Quality Intelligence, UCB
Sean Burke, Senior Director, Regional Lead, International Pharmacovigilance, MSD
Gloria Bustos, Global Head Global Patient Safety, Vantive
Mattia Calissano, Director, Head of Pharmacovigilance, Orchard Therapeutics
Natacha Carragher, Senior Advisor, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Patrick Caubel, Chief Safety Officer, Pfizer
Mark Cawley, Associate Director, R&D Procurement, Jazz Pharmaceuticals
Akhilesh Chamediya, Global Medical Director, Patient Safety Lead, AstraZeneca & Alexion
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
Pawel Chomiak, Associate Director, Clinical Data Management, MSD
David Chonzi, Independent Pharma Physician, Independent PV Expert
Mugdha Chopra, Co-founder and Director, AWINSA Life Sciences
Rishi Chopra, Executive Director, Global Head of Pharmacovigilance Regions, CSL
Mircea Ciuca, AVP, Head Global Medical Safety, Organon
Jan Cleerbout, Deputy QPPV, Johnson & Johnson Innovative Medicine
Emilio Clementi, Full Professor of Pharmacology, University of Milano
Galina Cordero, Head of Pharmacovigilance Department, QPPV, JSC Farmak
Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Michelle Motta Dardeno, Vice President, Head of Global Patient Safety, Aurinia
Abiola David, Senior Director, Global Process Owner, ICSR Management, PV Operations, GSK
Barbara Dawson, Vice President, Head of Pharmacovigilance Operations, GSK
Anthonius (Ton) de Boer, Chairman, CBG-MEB Medicines Evaluation Board
Jolanda De Bruijne, Senior Director, Head of PV Compliance, Teva Pharmaceuticals
Fabio De Gregorio, Vice President, Head Of Drug Safety Europe, Shionogi BV
Peter De Veene, Associate Vice President, Global QPPV, MSD
Daniela Di Cosmo, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals
Elisabetta Di Martino, Director, GCP, GVP & GLP, Quality Assurance, Orchard Therapeutics
Francesca Dickins, Advisor, Medicines Quality Organization, Eli Lilly
Steve Dingman, Vice President, Pharmacovigilance, Head of Safety, Merus NV
Moin Don, Lead, ISoP South Asia Chapter, ISoP
Joan D'souza, Local QPPV, Independent PV Expert
Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals
Ekaterina Edle von Dall'Armi, Local QPPV, Germany, GSK
Vicki Edwards, Vice President, Pharmacovigilance Excellence & International QPPV, AbbVie
James Eldridge, Director, Global Drug Safety, Y-mAbs
Mirko Fedrigo, Head of Drug Safety Europe and Global PV Quality System, EU/UK QPPV, Italfarmaco
Sebastian Fischer, Regulatory Strategy Principal, TUV SUD Product Service GmbH
Mr Christopher Flood, Independent PV Expert
Paraskevi Floroskoufi, CHC Regional PV Head, Europe and Eurasia, Opella Healthcare Group
Suzanne Foncin, Scientific Director, Safety Evaluation & Risk Management, GSK
Antonella Fretta, Senior Director, Aggregate Reporting Team Lead, Pfizer
Stewart Geary, Global Safety Officer, Eisai
Irina Ghiorghiu, Global Lead Vendor Management, Opella Healthcare Group
Magda Godula, Director, Regional Safety Platform Lead, Pfizer
Shay Goldstein, Senior Director, Global Safety Lead Oncology, Bristol Myers Squibb
Pedro Gomes, Global Director, Pharmacovigilance (PV) Quality Assurance Lead, MSD
Ilaria Grisoni, Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV, Jazz Pharmaceuticals
Luis Guedes, Global Product Safety Science Lead, Sobi
Israel Gutierrez, Chief Medical Officer, TLR Therapeutics Inc
Rania Haggag, Associate Director, Pharmacovigilance Strategy and Business Excellence, Organon
Pat Harding, Senior Director, International PV Operations (PSMF), Eli Lilly and Company
Fabian Heisig, Chief Medical Officer, Senior Vice President, Head Global Drug Safety & QPPV, Grunenthal
Janni Hermansen, Director, Head of Global Safety Operations, Ferring Pharmaceuticals A/S
Laura Hiles, Senior Clinical Safety Director, Roche
Peter Hjelmstrom, Director and Chief Executive Officer, Uppsala Monitoring Centre
Tina Ho, Senior Director, Vendor Relationship Management, Regeneron Pharmaceuticals Inc.
Paul Hoericke, Global Procurement Category Lead PV, Bayer AG
Tanja Hoffman, Owner, Executive Consultant, Independent PV Expert
Prabjot Hunjan, DIRECTOR, Independent PV Expert
Tuula Ikonen, Head of Pharmacovigilance Department, EORTC
Maximilian Jacobs, Head of Vendor Management, Pharmacovigilance, Bayer AG
Philip Jones, Senior Director, Disease Area Cluster Lead, CVMWH, Pfizer
Rafael Josupeit, EEA QPPV, Procter & Gamble
Juhaeri Juhaeri, Vice President & Global Head, Epidemiology and Benefit-Risk, Sanofi
Agnieszka Jutróczki, Manager, Global Case Management, Moderna
Mette Stie Kallesøe, Head of Pharmacovigilance, QPPV, Hansa Biopharma
Elena Keller, Director, PV, RA, Quality and Medical Operations, Local QPPV, Ipsen Pharma GmbH
Ranjana Khanna, Global Director, GVP, QA, R&D Quality, BeiGene
Jean Kilgour-Christie, Deputy EU QPPV Head, UK QPPV, sandoz
Ben Kitchens, Associate Director, Medical Devices, Diagnostics Lead, Otsuka Pharmaceutical Companies (U.S.)
Sven Kohler, Vice President, EU-QPPV and Head Regional Patient Safety and PV, Boehringer Ingelheim
Peter Kohut, Senior Director, Head of Pharmacovigilance, Alvotech
Anna Konczak, EU QPPV, Polpharma
Mohammed Ali Kotal, EU QPPV and Head of QPPV Office, Sandoz International GmbH
Smruti Kothari, Associate Director, Global Patient Safety, Quality and Compliance, Regeneron
Monika Kowalska, Director, Global Case Management, Moderna
Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer
Sergiy Kryvych, Senior Drug Safety Officer & Medical Advisor, Deputy Local Pharmacovigilance Responsible Person, Pfizer
Jürgen Kübler, Co-Chair, ASA Biopharm Safety Working Group
Thomas Kuckuk, Head, Pharmacovigilance Systems Management, Novartis
Marie-Laure Kurzinger, Head of Pharmacoepidemiology, General Medicine, Sanofi
Graeme Ladds, CEO & Owner, PharSafer
Amir Lahouegue, Director, Patient Safety & Cluster Lead, France & Benelux, AstraZeneca
Jost Leemhuis, Safety Science Partner and Global Business Lead, Roche
Claudia Lehmann, Vice President, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Fabio Lievano, Vice President, Safety Science, AbbVie
Luiz Lima, Vice President, Head of Neuroscience, Global Patient Safety, Ipsen
Rita Lobatto, Vice President, Pharmacovigilance & QPPV, Pharming Group
Han Ma, Senior Vice President, Chief Safety Officer, BeiGene
Ryan Magee, Founder & Vice President of Engineering, IMPAQT Engineering
Asif Mahmood, Vice President, Medical Safety & Pharmacovigilance, AskBio
Balaji Malla, Head of Pharmacovigilance, EU & UK QPPV, Dr Reddys Laboratories Limited
Valentina Mancini, Senior Director, Pharmacovigilance, QPPV, Shionogi & TransCelerate
Monika Manske, Lead Quality Management, Viatris
Marcin Marciniak, Senior Director, Global Safety and PV Expert WHC, Gedeon Richter Switzerland
Daniela Marcozzi, Head of Corporate Clinical Safety, Pharmacovigilance and R&D Compliance, EU & UK QPPV, Fidia farmaceutici spa
Anastazja Markowska, Director, Polish Society of Pharmacovigilance
Jorgen Matz, Global Head, Pharmacovigilance & Clinical Quality, INSUD PHARMA
Petros Mavrogenis, Head, Vigilance Process Excellence, Novartis
Bruno Mendez, Vice President, Global Head, Pharmacovigilance Quality, Sanofi
Fabio Miceli, EU QPPV, Norgine
Danielle Middleton, Director, Safety Physician, Jazz Pharmaceuticals
Sanjeev Miglani, Founder and Director, AWINSA Life Sciences
Rania Mouchantaf, Executive Director, Health Canada
Marianne Mounir, Senior Global Auditor, Bayer
Harminder Mudhar, Director, Device & Digital Safety, AstraZeneca
Céline Muffang, Associate Director, Medical Safety & Pharmacovigilance, AskBio
Sutirtha Mukhopadhyay, Senior Associate Director, Senior Patient Safety Physician, Boehringer Ingelheim
Yvonne Nanciu, Country Head, Pharmacovigilance, Deputy EU QPPV, Bayer
Magnus Nord, Vice President, Global Patient Safety BioPharma, AstraZeneca
Minhaj Obeidullah, Global Head, Governance & Risk, Novartis
Kieran O'Donnell, Director, Independent PV Expert
Nadine O'Hare, Senior Director, Global Patient Safety, PV Intelligence, Regeneron
Louise O'Keeffe, Senior Safety Development Director, Roche
Attila Oláh, Vice President, Head, Global Patient Safety, EU-QPPV, Gedeon Richter PLC
Shaloo Pandhi, Global Head, Patient Safety, sandoz
Devang Patel, Head of Global Pharmacovigilance, Zydus Lifesciences Limited
Krupa Patel, Senior Safety Scientist, Global Patient Safety, Ipsen
Anna Pelnikevich, Director, Head of QPPV Office, Merck
Teodora Perger, Senior Medical Director, Global Safety Physician, AstraZeneca
Catherine Pons, Affiliate Patient Safety Director, Roche
Elena Prokofyeva, Head of Drug Safety Unit, DG Post, FAMHP - Federal Agency for Medicines and Health Products in Belgium
Mandeep Rai, Global Head of PV Performance Excellence, Kyowa Kirin Co., Ltd.
Daria Giusi Rasà, Head of Corporate Pharmacovigilance, EU/UK QPPV, Alfasigma
Nibedita Rath, Scientific Director, Open Source Pharma Foundation
Maria Jose Reneses, Senior Director, Deputy EU QPPV & Head of PSMF Team, Takeda
Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Hadir Rostom, Independent PV Expert - Lecturer, Modern Sciences And Arts University
Zina Sadeq, Director, Regional PV and Alliance Management, UK QPPV, Amicus Therapeutics
Kishore Saha, Chief Specialist, Lundbeck
Myriam Salem, National Good Pharmacovigilance Practices Inspection Program Coordinator, Health Canada
Dr Delphine Saragoussi, Head of Pharmacoepidemiology, Vaccines, Patient Safety & Pharmacovigilance, Sanofi
Monika Sarnecka, Associate Director, Clinical Data Management, MSD
Yvonne Schäfer, Head of Patient Safety and Pharmacovigilance Systems Business Solutions, Boehringer Ingelheim International
Rudi Scheerlinck, Global Program Safety Lead, Merck Healthcare Oncology
Reinhold Schilling, Head of Global Pharmacovigilance, EU QPPV, Wörwag Pharma
Petra Schmid, Team Lead Drug Safety, Deputy EU QPPV, AOP Health GmbH
Eveline Schurink, Vice President, Clinical Development, Patient Safety & Medical Affairs, Alvotech
Maurizio Sessa, Associate Professor, Pharmacovigilance and Pharmacoepidemiology, University of Copenhagen
Howard Snow, Vice President, Global Head of Pharmacovigilance, Sobi (Swedish Orphan Biovitrum)
John Solomon, Head of Pharmacovigilance, UK & Ireland, Sanofi
Jens-Ulrich Stegmann, Senior Vice President, Head Clinical Safety and Pharmacovigilance, EU QPPV, GSK
Ariane Stollenwerk, Director, Head of Safety Central Europe & APAC, UCB
Johanna Strandell, Director, Patient Safety, Camurus AB
Maria Stupar, Senior Director, Head Safety & Benefit Risk, Opioids and Generics, Grünenthal GmbH
Karthick Sukumaran, Director, Technology Enablement, Intelligent Safety Automation, Roche Products Ltd
Sarah Tarnowsky, PSMF Coordinator & Specialist Quality Management, Viatris
Stéphanie Tcherny-Lessenot, Global Head, Benefit-Risk Evaluation, Sanofi
Anders Thyme, Director, Pharmacovigilance, Ascendo Biotechnology
Phil Tregunno, Deputy Director, Patient Safety Monitoring, MHRA
Kamil Trzaska, Manager, Global Case Management, Moderna
Marco Tuccori, Associate Professor of Pharmacology, Department of Diagnostic & Public Health, University of Verona
Alina Tudor, Global Head, Medical Evaluation and ICSR Review, Kyowa Kirin International
Vivienne van de Walle, Medical Director, PT&R
Bert Van Leeuwen, Senior Director, Deputy QPPV, Astellas Pharma Europe BV
Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)
Sarah Vaughan, Head of Vigilance Operations, MHRA
Deepa Venkataraman, Vice President, Patient Safety and Pharmacovigilance, Corcept Therapeutics
Sriram Venkateswaran, Safety Data Science Director, Hoffmann la Roche Ltd
Michael von Forstner, Global Head, Safety Science, Sobi (Swedish Orphan Biovitrum)
Nisha Vora, Senior Safety Scientist, Global Patient Safety, Ipsen
Ivana Vranic, Director, Safety Risk Lead, Inflammation & Immunology, Pfizer
Rachel Wallace, Independent PV Expert
Colleen Walsh, Vice President, Global Safety Operations, Alnylam Pharmaceuticals
Rebecca Webb, Senior Director, Safety, Vigilance and Medical Affairs QA, AbbVie
Heinz Weidenthaler, Senior Director, Safety Strategy Lead, BioNTech
Shanti Werther, Executive Director, Global Safety Head, Immunology Patient Safety, Biopharma, AstraZeneca
Robert Westphal, Digital Lead IT Pharma, Chief Medical Office, Bayer
Dieter Wetzel, Head of Medical Science, toclinco GmbH
Sridhar Yeshamaina, Vice President, Global Patient Safety, Amneal Pharmaceuticals Ltd
Aya Zaghloul, Associate Director, GPS International Pharmacovigilance Operations, Eli Lilly and Company
Dimitrios Zampatis, Director, Product Patient Safety, Sandoz
Mr Gyorgy Zorenyi, Senior Medical Director, Medical Safety, Jazz Pharmaceuticals
Get Involved At
World Drug Safety Congress
Sponsorship & Exhibition Sales
Jamie Blowfield
jamie.blowfield@terrapinn.com
+44 20 81641599
Grace Gowler
grace.gowler@terrapinn.com
+44 20 3481 8981
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events